Drug keeps ovarian cancer in check, study finds
Wednesday, June 9, 2010 - 10:41
in Health & Medicine
In a study of 1,873 women with untreated ovarian cancer, Avastin extended progression-free survival by 39% compared with standard chemotherapy alone. The cancer drug Avastin extends progression-free survival by 39% in ovarian cancer patients, a significant improvement in a cancer that has proved extremely difficult to treat.